Yu Peng

697 total citations
39 papers, 556 citations indexed

About

Yu Peng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yu Peng has authored 39 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Yu Peng's work include Lung Cancer Treatments and Mutations (9 papers), Immune Cell Function and Interaction (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yu Peng is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Immune Cell Function and Interaction (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yu Peng collaborates with scholars based in China, United States and Italy. Yu Peng's co-authors include Yi Qing, Qing Li, Hao Luo, Tao Ren, Shufeng Zhou, Dong Wang, Mengxia Li, Dong Wang, Thomas Kodadek and Yanli Xiong and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Yu Peng

35 papers receiving 551 citations

Peers

Yu Peng

ONCOL

PRM

IMMUN

Kakil Ibrahim Rasul Qatar

Eleonora Lai Italy

Raffaele Armentano Italy

Yanping Zhong China

Anil K. Rustgi United States

Zhijun Xu China

Yongsheng Yang China

Kefeng Wang China

Luis Aparicio Spain

Kakil Ibrahim Rasul Qatar

Yu Peng

183 ×0.8

192 ×0.8

ONCOL

116 ×0.8

PRM

122 ×1.2

59 ×0.7

IMMUN

Citations per year, relative to Yu Peng Yu Peng (= 1×) peers Kakil Ibrahim Rasul

Countries citing papers authored by Yu Peng

Since Specialization

Citations

This map shows the geographic impact of Yu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Peng more than expected).

Fields of papers citing papers by Yu Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Peng. The network helps show where Yu Peng may publish in the future.

Co-authorship network of co-authors of Yu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Peng. A scholar is included among the top collaborators of Yu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Peng. Yu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Feiye, et al.. (2025). PTGFRN promotes non-small cell lung cancer malignant progression and reprograms BCAA metabolism by activating STAT3/BCAT1 pathway. Biochemical Pharmacology. 242(Pt 4). 117445–117445.

Zhang, Sheng, et al.. (2024). Harvesting multidirectional wind energy based on flow-induced vibration triboelectric nanogenerator with directional tuning mechanism. Sensors and Actuators A Physical. 379. 115974–115974. 5 indexed citations

Peng, Dan, Yu Peng, Guang Zhao, et al.. (2024). The new pattern for dual NOTCH pathway involving nuclear transcription and mitochondrial regulation supports therapeutic mechanism of 4-butyl benzophenone derivatives against SIRS. Free Radical Biology and Medicine. 223. 306–324. 5 indexed citations

Zhang, Hui, Bo Li, Ke Hu, et al.. (2024). Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma. Archives of Biochemistry and Biophysics. 754. 109929–109929. 2 indexed citations

Peng, Yu, Xueqin Guo, Di Liu, et al.. (2024). Identifying a cis-element in PtoCP1 promoter for efficiently controlling constitutive gene expression in Populus tomentosa. PeerJ. 12. e18292–e18292.

Xu, Zhijian, Hui Zhang, Dandan Yu, et al.. (2023). Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma. Archives of Biochemistry and Biophysics. 747. 109771–109771. 3 indexed citations

Peng, Yu, Jianxin Liu, Yong Zhang, et al.. (2022). The post-transcriptional inhibition of CXCR4 expression by miR-139 regulates the proliferation of human kidney cancer cells. Acta Biochimica Polonica. 69(1). 189–195. 2 indexed citations

Zhu, Wenjing, et al.. (2022). STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression. Molecular and Cellular Biochemistry. 477(3). 865–875. 7 indexed citations

Li, Qing, Zhiwei Zhou, Lu Jia, et al.. (2021). PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer. Molecular Therapy. 30(2). 621–631. 23 indexed citations

10.

Yang, Xiao, Yu Peng, Xuan Jiang, et al.. (2018). The regulatory role of APE1 in epithelial‐to‐mesenchymal transition and in determining EGFR‐TKI responsiveness in non‐small‐cell lung cancer. Cancer Medicine. 7(9). 4406–4419. 29 indexed citations

11.

Peng, Yu, Ye Chen, Xi Zhang, et al.. (2018). Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy. Journal of Cancer Research and Clinical Oncology. 144(7). 1339–1346. 6 indexed citations

12.

Qing, Yi, Qing Li, Tao Ren, et al.. (2015). Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer. Drug Design Development and Therapy. 9. 901–901. 152 indexed citations

13.

Xiong, Yanli, Zejun Zhou, Yu Peng, et al.. (2014). Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study. Medical Oncology. 31(12). 369–369. 16 indexed citations

14.

Ren, Tao, Jinlu Shan, Yi Qing, et al.. (2014). Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway. Drug Design Development and Therapy. 8. 2517–2517. 22 indexed citations

15.

Peng, Yu, et al.. (2014). DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study. Oncology Letters. 9(1). 491–497. 8 indexed citations

16.

Li, Zheng, Yi Qing, Wei Guan, et al.. (2014). Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy. Cancer Chemotherapy and Pharmacology. 74(4). 777–786. 51 indexed citations

17.

Xu, Huijun, et al.. (2013). The Stability and Anti-cancer Role of Immune Lymph from Larinioides cornutus (Araneae: Araneidae). 29. 237–250. 1 indexed citations

18.

Liu, Yuee, Qiang Lin, Fanjie Meng, et al.. (2013). High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study. Radiation Oncology. 8(1). 198–198. 20 indexed citations

19.

Lin, Qiang, Yuee Liu, Na Wang, et al.. (2013). Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial. Radiation Oncology. 8(1). 201–201. 26 indexed citations

20.

Peng, Yu. (2012). The relationship between MBL genotype and lung histopathologic lesions of Mycoplasma ovipneumoniae pneumonia in sheep. Zhongguo yufang shouyi xuebao. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact